Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-06-29Clinical Trial Update: Tadalafil and Lenalidomide Maintenance With or Without Activated Marrow Infiltrating Lymphocytes (MILs) in High Risk Myeloma [Phase 2]
Phase 2 trial evaluating tadalafil and lenalidomide maintenance with or without MILs in high-risk multiple myeloma; trial completed with res…
-
CLINICAL_TRIALS trial_result · 2020-06-17Clinical Trial Update: Doxil® + Melphalan + Velcade (DMV) in Relapsed/Refractory Multiple Myeloma [Phase 1, Phase 2]
Phase 1/2 study of Doxil plus Melphalan plus Velcade (DMV) in relapsed/refractory multiple myeloma; trial terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2020-05-27Clinical Trial Update: Allogeneic Stem Cell Transplantation for Multiple Myeloma and Myelofibrosis [Phase 2]
Phase 2 trial update on allogeneic stem cell transplantation for multiple myeloma and myelofibrosis; the study status is terminated with pos…
-
CLINICAL_TRIALS trial_result · 2020-05-26Clinical Trial Update: Study to Evaluate the Safety and Efficacy of KITE-585 in Participants With Relapsed/Refractory Multiple Myeloma [Phase 1]
Phase 1 trial of KITE-585 in relapsed/refractory multiple myeloma was terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-05-18Clinical Trial Update: Meloxicam vs Placebo for Mobilization [Phase 2]
Phase 2 trial comparing Meloxicam to placebo for mobilization in hematologic malignancies has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-05-13Clinical Trial Update: An Open-Label, Phase 1b Study of Acalabrutinib With and Without Dexamethasone in Subjects With Multiple Myeloma [Phase 1]
Phase 1b open-label trial evaluating acalabrutinib with and without dexamethasone in adults with multiple myeloma; study completed with resu…
-
CLINICAL_TRIALS trial_result · 2020-05-12Clinical Trial Update: Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy [Phase 2]
Phase 2 trial update on allogeneic bone marrow transplantation with less intensive therapy; the study was terminated with results posted in …
-
CLINICAL_TRIALS trial_result · 2020-05-11Clinical Trial Update: Continued, Long-Term Follow-Up and Lenalidomide Maintenance Therapy for Patients on BMT CTN 0702 Protocol (BMT CTN 07LT) [Phase 3]
Long-term follow-up and lenalidomide maintenance therapy results from a Phase 3 trial in multiple myeloma (BMT CTN 0702).
-
CLINICAL_TRIALS trial_result · 2020-05-05Clinical Trial Update: High-Dose Gemcitabine, Busulfan and Melphalan With Hematopoietic-Cell Support for Patients With Poor-Risk Myeloma [Phase 2]
Phase 2 trial evaluating high-dose gemcitabine, busulfan, and melphalan with hematopoietic-cell support in poor-risk myeloma completed with …
-
CLINICAL_TRIALS trial_result · 2020-04-29Clinical Trial Update: Pembrolizumab (MK-3475) in MM Patients With Residual Disease [Phase 2]
Phase 2 clinical trial update of pembrolizumab (MK-3475) in multiple myeloma patients with residual disease has completed.
-
CLINICAL_TRIALS trial_result · 2020-04-28Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Two Doses of GSK2857916 in Participants With Multiple Myeloma Who Have Failed Prior Treatment With an Anti-CD38 Antibody [Phase 2]
A Phase 2 study evaluating two doses of belantamab mafodotin in multiple myeloma patients who previously failed anti-CD38 therapy; results h…
-
CLINICAL_TRIALS trial_result · 2020-04-21Clinical Trial Update: A Randomized Trial to Compare Busulfan + Melphalan 140 mg/m2 With Melphalan 200 mg/m2 as Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma [Phase 3]
Phase 3 randomized trial comparing busulfan + melphalan 140 mg/m2 vs melphalan 200 mg/m2 as conditioning for autologous stem cell transplant…
-
CLINICAL_TRIALS trial_result · 2020-04-21Clinical Trial Update: Safety & Efficacy Study High Dose Evomela Injection for MA Conditioning in MM Patients With Autologous Transplantation [Phase 2]
Phase 2 trial update on high-dose Evomela injection for conditioning in autologous stem cell transplantation for multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2020-04-17Clinical Trial Update: Pomalidomide, Bortezomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 1, Phase 2]
Phase 1/2 trial evaluating pomalidomide, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma has completed with results…
-
CLINICAL_TRIALS trial_result · 2020-04-06Clinical Trial Update: Zoledronic Acid in Patients With Multiple Myeloma and Asymptomatic Biochemical Relapse [Phase 4]
Phase 4 trial update evaluating zoledronic acid in patients with multiple myeloma and asymptomatic biochemical relapse has completed.
-
CLINICAL_TRIALS trial_result · 2020-04-02Clinical Trial Update: Combination Chemotherapy in Treating Patients With Multiple Myeloma [Phase 3]
Phase 3 trial update for combination chemotherapy in treating patients with multiple myeloma and plasma cell neoplasm.
-
CLINICAL_TRIALS trial_result · 2020-04-02Clinical Trial Update: Thalidomide and Prednisone Following Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma [Phase 2]
Phase 2 clinical trial of thalidomide and prednisone after peripheral stem cell transplantation for multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2020-03-25Clinical Trial Update: Lenalidomide and Dexamethasone With or Without Anakinra in Treating Patients With Early Stage Multiple Myeloma [Phase 1]
Phase 1 trial evaluating lenalidomide and dexamethasone with or without anakinra in early-stage multiple myeloma; completed with results pos…
-
CLINICAL_TRIALS trial_result · 2020-03-19Clinical Trial Update: Combination Immunotherapy and Autologous Stem Cell Transplantation for Myeloma [Phase 2]
Phase 2 trial updating results for combining immunotherapy with autologous stem cell transplantation in myeloma.
-
CLINICAL_TRIALS trial_result · 2020-03-04Clinical Trial Update: CART-19 Post-ASCT for Multiple Myeloma [Phase 2]
Phase 2 clinical trial updating CART-19 post-autologous stem cell transplant for multiple myeloma; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2020-03-03Clinical Trial Update: High-Dose Weekly Carfilzomib Plus Cyclophosphamide and Dexamethasone in the Treatment of Relapsed Multiple Myeloma [Phase 2]
Phase 2 trial evaluating high-dose weekly carfilzomib with cyclophosphamide and dexamethasone in relapsed multiple myeloma has completed wit…
-
CLINICAL_TRIALS trial_result · 2020-02-26Clinical Trial Update: Study Testing Radium-223 Dichloride in Relapsed Multiple Myeloma [Phase 1, Phase 2]
A study evaluating radium-223 dichloride in relapsed multiple myeloma was terminated; results were posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-02-25Clinical Trial Update: Mel vs BUCY+VP-16 Conditioning Regimen for MM Undergoing Auto-HSCT [Phase 2, Phase 3]
Phase 2/3 clinical trial comparing Mel vs BUCY+VP-16 conditioning for multiple myeloma patients undergoing autologous hematopoietic stem cel…
-
CLINICAL_TRIALS trial_result · 2020-02-07Clinical Trial Update: Study Comparing Daratumumab, Lenalidomide, Bortezomib, and Dexamethasone (D-RVd) Versus Lenalidomide, Bortezomib, and Dexamethasone (RVd) in Subjects With Newly Diagnosed Multiple Myeloma [Phase 2]
Phase 2 study comparing D-RVd (daratumumab–lenalidomide–bortezomib–dexamethasone) versus RVd (lenalidomide–bortezomib–dexamethasone) in newl…
-
CLINICAL_TRIALS trial_result · 2020-02-06Clinical Trial Update: Melphalan and Stem Cell Transplant Before Total-Body Irradiation and Donor Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating melphalan and stem cell transplant before total-body irradiation and donor stem cell transplant in pat…